Angiotensin II Blockade for Chronic Allograft Nephropathy - Contacts and Locations

Angiotensin II Blockade for Chronic Allograft Nephropathy

This study is ongoing, but not recruiting participants.

Study NCT00067990. Last updated on August 6, 2008. Information provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00067990

Locations


United States, Minnesota
	University of Minnesota
	Minneapolis, Minnesota, United States, 55455
	Hennepin County Medical Center
	Minneapolis, Minnesota, United States, 55415

Sponsors and Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Merck

Investigators


Principal Investigator:	Hassan N. Ibrahim, M.D., M.S.	University of Minnesota

Principal Investigator:	Bertram Kasiske, M.D.	Hennepin County Medical Center - Minneapolis